Founded in Warren Township, United States, Aquestive Therapeutics is a pharmaceutical company dedicated to developing innovative medicines and therapeutic solutions, particularly for central nervous system diseases. The company's core mission is to advance medical treatments, solve therapeutic challenges, and improve patient lives. Aquestive specializes in creating oral film medications, offering a unique delivery method that addresses barriers in existing treatment options and introduces new paradigms for managing complex conditions.

Notable figures associated with Aquestive Therapeutics include a team of experienced pharmaceutical professionals and researchers. The company has secured strong intellectual property with over 200 patents and has delivered more than 2 billion doses of its medications globally. Aquestive's significant achievements include the development of a robust late-stage proprietary product pipeline and establishing itself as a leader in the oral film medication market. Through its innovative solutions, Aquestive has made a substantial impact on the therapeutic landscape, enhancing treatment efficacy and patient compliance.